ACCENDRA HEALTH INC (ACH)
Health Care · Home healthcare equipment and medical supplies · NYSE
Accendra Health delivers home healthcare equipment and medical supplies through Apria and Byram Healthcare brands, though the company faces severe financial headwinds including 75% revenue decline, negative profitability, and substantial debt relative to market value.
What ACCENDRA HEALTH INC does
Accendra Health (formerly Owens & Minor) is a leading nationwide provider of home healthcare equipment, medical supplies, and related services through its trusted brands Apria and Byram Healthcare. The company serves patients, providers, and insurers by delivering products and support for chronic, complex, and acute health conditions including diabetes treatment, home respiratory therapy, sleep apnea treatment, wound care, and other home medical equipment needs. Revenue is generated primarily through fee-for-service and capitation arrangements with government payors (Medicare, Medicaid), commercial insurers, and home health agencies.
Themes: ["Home healthcare equipment and services","DME (durable medical equipment)","Chronic disease management","Respiratory therapy","Sleep apnea treatment","Wound care","Medicare reimbursement","Medical supplies distribution"]
Fundamentals
- Price$3.30 as of 2026-07-09 close
- Market cap$255M as of 2026-07-10
- 1-year return-61.8% as of 2026-07-09 close
- Net margin-39.8% as of 2026-07-10
- Gross margin+46.0% as of 2026-07-10
- ROE-50.9% as of 2026-07-10
- Debt / equity3.41 as of 2026-07-10
- Revenue growth (YoY)-74.7% as of 2026-07-10
- Revenue CAGR (3y)-34.8% SEC XBRL
- Beta1.60 as of 2026-07-10
Dividend: 3-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Significant revenue decline of -74.67% YoY and unprofitable operations with -39.84% net margin reflect material business deterioration and ongoing operational challenges","High debt load ($1.52 billion long-term debt plus $581 million current portion) against a market cap of $255 million creates substantial refinancing and solvency risk, particularly as the company reported negative equity (deficit of $465 million)","Recently divested the Products & Healthcare Services business (December 2025) for $375 million with only a retained 5% equity interest, representing a strategic shift that may further reduce scale and revenue-generating capacity"]
Competitors & peers
- AdaptHealth Corp.
- Lincare
- Inogen
- Viemed Healthcare, Inc.
- Quipt Home Medical
- Cardinal Health
- Rotech
- CVS Health Corporation (pharmacy benefit manager)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.